The inhibitory effect of this combination treatment on cell proliferation was confirmed using other multiple myeloma cell lines such as IM-9 (IL-6-independent) and MM.1R (IL-6-dependent) cells (Supplementary Figure 3 and Supplementary Figure 4, Supplementary Table 1 and Supplementary Table 2). The gene discussed is IL6; the disease is AL amyloidosis.